ID   YDOV-161
AC   CVCL_A1KD
SY   YongDong OVarian-161
DR   GEO; GSM4013284
DR   GEO; GSM4013285
DR   Wikidata; Q102115146
RX   PubMed=19188485;
RX   PubMed=24164300;
RX   PubMed=31615043;
CC   Population: Korean.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
RX   PubMed=19188485; DOI=10.1369/jhc.2009.953257; PMCID=PMC2675069;
RA   Cho H., Kim J.-H.;
RT   "Lipocalin2 expressions correlate significantly with tumor
RT   differentiation in epithelial ovarian cancer.";
RL   J. Histochem. Cytochem. 57:513-521(2009).
//
RX   PubMed=24164300; DOI=10.3109/07357907.2013.849722;
RA   Cho H., Lee Y.S., Kim J., Chung J.-Y., Kim J.-H.;
RT   "Overexpression of glucose transporter-1 (GLUT-1) predicts poor
RT   prognosis in epithelial ovarian cancer.";
RL   Cancer Invest. 31:607-615(2013).
//
RX   PubMed=31615043; DOI=10.3390/cancers11101553; PMCID=PMC6826427;
RA   Choi J.-A., Kwon H., Cho H., Chung J.-Y., Hewitt S.M., Kim J.-H.;
RT   "ALDH1A2 is a candidate tumor suppressor gene in ovarian cancer.";
RL   Cancers (Basel) 11:1553.1-1553.18(2019).
//